Bacalso, Rico .

HRN: 28-68-99  Sex: Male

Patient Encounter


Audit Details

Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
03/17/2026
CEFTRIAXONE 1G (VIAL)
03/17/2026
03/24/2026
IV
2g
OD
Multiple Avulsed Wound
Pending Pharmacy Acceptance 

 Indication:  Empiric    Type of Infection:  Bone & JointSkin & Soft Tissue    Compliance to guidelines: